Article
Disease outcomes and biomarkers of progression in smouldering Waldenström macroglobulinaemia.
British journal of haematology - 1 Oct 2021
Zanwar Saurabh, Abeykoon Jithma P, Ansell Stephen M, Gertz Morie A, Colby Colin, Larson Dirk, Paludo Jonas, He Rong, Warsame Rahma, Greipp Patricia T, King Rebecca L, Thompson Carrie A, Witzig Thomas E, Lacy Martha Q, Gonsalves Wilson, Nowakowski Grzegorz S, Dingli David, Go Ronald S, Habermann Thomas M, Vincent Rajkumar S, Kyle Robert A, Kumar Shaji, Kapoor Prashant
Abstract excerpt
Patients with asymptomatic/smouldering Waldenström macroglobulinaemia (SWM) have a variable risk of progression to active WM. Our study evaluated 143 patients with SWM consecutively seen between January 1996 and December 2013. With a median [95% confidence interval (CI)] follow-up of 9·5 [8·1-11·5] years, the cumulative rate of progression was 11% at 1 year, 38% at 3 years and 55% at 5 years. On multivariate...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.